Cadeler A/S
CDLRNYSEIndustrials● Active
$23.41
$-0.39(-1.64%)
Market Cap$2.1B
P/E Ratio—
52W High$30.01
52W Low$15.37
Cadeler A/S（CDLR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CDLR · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.60B | $0.25B | $0.11B | $0.11B | $0.06B |
| Cost of Revenue | $0.23B | $0.13B | $0.06B | $0.05B | $0.04B |
| Gross Profit | $0.37B | $0.12B | $0.05B | $0.06B | $0.02B |
| Gross Margin %(computed) | 61.26% | 48.84% | 48.46% | 52.71% | 35.96% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.07B | $0.05B | $0.04B | $0.01B | $0.01B |
| Operating Income | $0.30B | $0.07B | $0.01B | $0.04B | $0.01B |
| Operating Margin %(computed) | 49.81% | 27.92% | 13.30% | 38.70% | 18.27% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.28B | $0.07B | $0.01B | $0.04B | $0.01B |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | $0.27B | $0.07B | $0.01B | $0.04B | $0.01B |
| Net Margin %(computed) | 45.17% | 26.16% | 10.59% | 33.40% | 12.23% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.08 | $0.76 | $0.23 | $0.88 | $0.23 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.05B | 0.04B | 0.03B |
| EBITDA | $0.40B | $0.12B | $0.05B | $0.06B | $0.03B |
| EBITDA Margin %(computed) | 67.15% | 50.04% | 45.71% | 59.12% | 44.81% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · EUR · B
深入了解Cadeler A/S
关于Cadeler A/S（CDLR）损益表
Cadeler A/S（CDLR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CDLR实现营收$0.60B，毛利润$0.37B（毛利率61.26%），净利润$0.27B（净利率45.17%）。
常见问题
CDLR · 4 问Cadeler A/S（CDLR）2025财年营收为$0.60B，同比up139.6%。
CDLR revenueCDLR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08